Treatment of Streptococcus mutans with antisense oligodeoxyribonucleotides to gtfB mRNA inhibits GtfB expression and function

FEMS Microbiology Letters

Volumn 264, Issue 1, 2006, Pages 8-14

  Guo, Qing Yu ^a,b   Xiao, Gang ^b   Li, Rui ^b   Guan, Su Min ^a   Zhu, Xiu Li ^a   Wu, Jun Zheng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Antisense oligodeoxyribonucleotide; Biofilm; Caries; Glucosyltransferase; Streptococcus mutans

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BACTERIAL PROTEIN; GLUCAN; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PROTEIN GTFB; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BIOMASS PRODUCTION; CARBOHYDRATE SYNTHESIS; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC CODE; GENETIC TRANSCRIPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STREPTOCOCCUS MUTANS;

ADJUVANTS, PHARMACEUTIC; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOFILMS; GENE EXPRESSION REGULATION, FUNGAL; GLUCOSYLTRANSFERASES; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; STREPTOCOCCUS MUTANS; THIONUCLEOTIDES;

STREPTOCOCCUS MUTANS;

EID: 33749444096     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2006.00378.x     Document Type: Article

References (32)

1. Baker BF & Monia BP (1999) Novel mechanisms for antisense-mediated regulation of gene expression. Biochim Biophys Acta 1489: 3-18.
2. Bennett CF & Cowsert LM (1999) Antisense oligonucleotides as a tool for gene functionalization and target validation. Biochim Biophys Acta 1489: 19-30.
3. Chirila TV, Rakoczy PE, Garrett KL, Lou X & Constable IJ (2002) The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides. Biomaterials 23: 321-342.
4. Donk NW, Blome AC, Spek E & Lokhorst HM (2006) New treatment strategies for multiple myeloma by targeting BCL-2 and the mevalonate pathway. Curr Pharm Des 12: 327-340.
5. Dubois M, Gilles KA, Hamilton JK, Rebers PA & Smith F (1956) Colorimetric method for determination of sugars and related substance. Anal Chem 28: 350-356.
6. Fujiwara T, Tamesada M, Bian Z, Kawabata S, Kimura S & Hamada S (1996) Deletion and reintroduction of glucosyltransferase genes of Streptococcus mutans and role of their gene products in sucrose dependent cellular adherence. Microb Pathog 20: 225-233.
7. Fujiwara T, Terao Y, Hoshino H, Kawabata S, Ooshima T, Sobue S, Kimura S & Hamada S (1998) Molecular analyses of glucosyltransferase genes among strains of Streptococcus mutans. Infect Immun 161: 331-336.
8. Fujiwara T, Hoshino T, Ooshima T & Hamada S (2002) Differential and quantitative analyses of mRNA expression of glucosyltransferases from Streptococcus mutans MT8148. J Dent Res 81: 109-113.
9. Fukushima K, Ikeda T & Kuramitsu HK (1992) Expression of Streptococcus mutans gtf genes in Streptococcus milleri. Infect Immun 60: 2815-2822.
10. Gaines S, James TC, Folan M, Baird AW & O'Farrelly C (2003) A novel spectrofluorometric microassay for Streptococcus mutans adherence to hydroxylapatite. J Microbiol Methods 54: 315-323.
11. Geller BL (2005) Antibacterial antisense. Curr Opin Mol The 7: 109-113.
12. Hamada S & Slade HD (1980) Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev 44: 331-384.
13. Harth G, Zamecnik PC, Tang JY, Tabatadze D & Horwitz MA (2000) Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamateyglutamine cell wall architecture and bacterial replication. Proc Natl Acad Sci USA 97: 418-423.
14. Hazlett KRO, Michalek SM & Banas JA (1998) Inactivation of the gbpA gene of Streptococcus mutans increases virulence and promotes in vivo accumulation of recombinations between the glucosyltransferase B and C genes. Infect Immun 66: 2180-2185.
15. Hung J, Rathsam C, Jacques NA & Giffard PM (2002) Expression of a Streptococcal glucosyltransferase as a fusion to a solute-binding protein in Lactobacillus fermentum BR11. FEMS Microbiol Lett 211: 71-75.
16. Li YH, Lau PCY, Lee JH, Ellen RP & Cvitkovitch DG (2001) Natural genetic transformation of Streptococcus mutans growing in biofilms. J Bacteriol 183: 897-908.
17. Li YH, Lau PCY, Tang N, Svensater G, Ellen RP & Cvitkovitch DG (2002) Novel two-component regulatory system involved in biofilm formation and acid resistance in Streptococcus mutans. J Bacteriol 184: 6333-6342.
18. Loo CY, Corliss DA & Ganeshkumar N (2000) Streptococcus gordonii biofilm formation: identification of genes that code for biofilm phenotypes. J Bacteriol 182: 1374-1382.
19. Markevics LJ & Jacques NA (1985) Enhanced secretion of glucosyltransferase by changes in potassium ion concentrations is accompanied by an altered pattern of membrane fatty acids in Streptococcus salivarius. J Bacteriol 161: 989-994.
20. Monchois V, Willemot R-M & Monsan P (1999) Glucansucrases: mechanism of action and architecture-function relationships. FEMS Microbiol Rev 23: 131-151.
21. Munro C, Michalek SM & Macrina FL (1991) Cariogenicity of Streptococcus mutans V403 glucosyltransferase and fructosyltransferase mutants constructed by allelic exchange. Infect Immun 59: 2316-2323.
22. Perry D, Wondrack LM & Kuramitsu HK (1983) Genetic transformation of putative cariogenic properties in Streptococcus mutans. Infect Immun 41: 722-727.
23. Rhodin NR, Van Tilburg MLJA, Oli MW, McArthur WP & Brady LJ (2004) Further characterization of immunomodulation by a monoclonal antibody against Streptococcus mutans Antigen P1. Infect Immun 72: 13-21.
24. Shiroza T & Kuramitsu HK (1993) Construction of a model secretion system for oral Streptococci. Infect Immun 61: 3745-3755.
25. Smith DJ, King WF, Barnes LA, Peacock Z & Taubman MA (2003) Immunogenicity and protective immunity induced by synthetic peptides associated with putative immunodominant regions of Streptococcus mutans glucan-binding protein B. Infect Immun 71: 1179-1184.
26. Stein CA, Benimetskaya L & Mani S (2005) Antisense strategies for oncogene inactivation. Semin Oncol 32: 563-572.
27. Tan XX, Actor JK & Chen Y (2005) Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection. Antimicrob Agents Chemother 49: 3203-3207.
28. Thurnheer T, van der Ploeg JR, Giertsen E & Guggenheim B (2006) Effects of Streptococcus mutans gtfC deficiency on mixed oral biofilms in vitro. Caries Res 40: 163-171.
29. Wang B & Kuramitsu HK (2003) Assessment of the utilization of the antisense RNA strategy to identify essential genes in heterologous bacteria. FEMS Microbiol Lett 220: 171-176.
30. Wang B & Kuramitsu HK (2005) Inducible antisense RNA expression in the characterization of gene function in Streptococcus mutans. Infect Immun 73: 3568-3576.
31. Yamashita Y, Bowen WH, Buren RA & Kuramitsu HK (1993) Role of the Streptococcus mutans gtf genes in caries induction in the specific-pathogen-free rat model. Infect Immun 61: 3811-3817.
32. Younson J & Kelly C (2004) The rational design of an anti-caries peptide against Streptococcus mutans. Molecular Diversity 8: 121-126.